[Recent progress in chemotherapy for hepatocellular carcinoma]

Nihon Naika Gakkai Zasshi. 2004 Aug 10;93(8):1660-5. doi: 10.2169/naika.93.1660.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carcinoma, Hepatocellular / drug therapy*
  • Chemotherapy, Adjuvant
  • Chemotherapy, Cancer, Regional Perfusion
  • Cisplatin / administration & dosage
  • Disease Progression
  • Doxorubicin / administration & dosage
  • Drug Interactions
  • Embolization, Therapeutic
  • Fluorouracil / administration & dosage
  • Hepatectomy
  • Humans
  • Infusions, Intra-Arterial
  • Infusions, Intravenous
  • Interferon-alpha / administration & dosage
  • Interferon-alpha / adverse effects
  • Liver Neoplasms / drug therapy*
  • Organoplatinum Compounds / administration & dosage
  • Oxaliplatin
  • Tamoxifen / therapeutic use
  • Tegafur / administration & dosage
  • Uracil / administration & dosage

Substances

  • Interferon-alpha
  • Organoplatinum Compounds
  • Oxaliplatin
  • Tamoxifen
  • Tegafur
  • Uracil
  • Doxorubicin
  • Cisplatin
  • Fluorouracil

Supplementary concepts

  • 1-UFT protocol